EPZM logo

Epizyme (EPZM) Depreciation And Amortization

Annual D&A

$5.25 M
+$1.26 M+31.68%

December 31, 2021

Summary

Performance

1-Year Change

+31.68%

3-Year Change

+398.67%

5-Year Change

+220.07%

15-Year Change

+220.07%

EPZM Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.25 M
EPZM annual depreciation & amortization is currently at an all-time high

3-Year Low

$5.25 M
EPZM annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
EPZM previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
EPZM next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$275.42 M
EPZM annual total expenses is $275.42 million

Annual Operating Expenses

$264.92 M
EPZM annual total operating expenses is $264.92 million

Annual Cost Of Goods Sold

$10.50 M
EPZM annual cost of goods sold is $10.50 million

Annual Interest Expense

$24.16 M
EPZM annual interest expense is $24.16 million

Quarterly D&A

$1.28 M
-$16.00 K-1.23%

June 30, 2022

Summary

Performance

3-Month Change

-1.23%

1-Year Change

-2.36%

3-Year Change

+513.4%

5-Year Change

+210.41%

EPZM Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.33 M
EPZM quarterly depreciation & amortization is currently -3.68% below its historical high of $1.33 million

3-Year Low

$1.28 M
EPZM quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$57.37 M
EPZM quarterly total expenses is $57.37 million

Quarterly Operating Expenses

$52.16 M
EPZM quarterly total operating expenses is $52.16 million

Quarterly Cost Of Goods Sold

$5.20 M
EPZM quarterly cost of goods sold is $5.20 million

Quarterly Interest Expense

$5.98 M
EPZM quarterly interest expense is $5.98 million

TTM D&A

$5.23 M
-$31.00 K-0.59%

June 30, 2022

Summary

Performance

3-Month Change

-0.59%

1-Year Change

+0.27%

3-Year Change

+522.74%

5-Year Change

+522.74%

EPZM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.26 M
EPZM TTM depreciation & amortization is currently -0.59% below its historical high of $5.26 million

3-Year Low

$5.23 M
EPZM TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$275.42 M
EPZM annual total expenses is $275.42 million

Annual Operating Expenses

$264.92 M
EPZM annual total operating expenses is $264.92 million

TTM Cost Of Goods Sold

$12.95 M
EPZM TTM cost of goods sold is $12.95 million

TTM Interest Expense

$24.09 M
EPZM TTM interest expense is $24.09 million

EPZM Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.7%-2.4%+0.3%
3 y3 years+398.7%+513.4%+522.7%
5 y5 years+220.1%+210.4%+522.7%

EPZM Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-3.7%at low-0.6%at low
5 y5-yearat high-84.0%-3.7%-83.3%-0.6%-83.9%
alltimeall timeat high-90.9%-3.7%-88.8%-0.6%-97.2%

Epizyme Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2022
-
$1.28 M(-1.2%)
$5.23 M(-0.6%)
Mar 2022
-
$1.30 M(-2.5%)
$5.26 M(+0.3%)
Dec 2021
$5.25 M(+31.7%)
$1.33 M(+0.8%)
$5.25 M(+0.4%)
Sep 2021
-
$1.32 M(+0.5%)
$5.22 M(+0.2%)
Jun 2021
-
$1.31 M(+2.4%)
$5.22 M(+9.7%)
Mar 2021
-
$1.28 M(-2.1%)
$4.75 M(+19.3%)
Dec 2020
$3.98 M(+374.3%)
$1.31 M(-0.2%)
$3.98 M(+38.0%)
Sep 2020
-
$1.31 M(+54.4%)
$2.89 M(+61.7%)
Jun 2020
-
$850.00 K(+66.0%)
$1.79 M(+56.0%)
Mar 2020
-
$512.00 K(+139.3%)
$1.15 M(+36.3%)
Dec 2019
$840.00 K(-20.2%)
$214.00 K(+1.9%)
$840.00 K(-3.9%)
Sep 2019
-
$210.00 K(+0.5%)
$874.00 K(-1.4%)
Jun 2019
-
$209.00 K(+1.0%)
$886.00 K(-1.3%)
Mar 2019
-
$207.00 K(-16.5%)
$898.00 K(-14.6%)
Dec 2018
$1.05 M(-35.8%)
$248.00 K(+11.7%)
$1.05 M(-13.3%)
Sep 2018
-
$222.00 K(+0.5%)
$1.21 M(-13.2%)
Jun 2018
-
$221.00 K(-38.8%)
$1.40 M(-12.1%)
Mar 2018
-
$361.00 K(-11.7%)
$1.59 M(-3.1%)
Dec 2017
$1.64 M
$409.00 K(+0.7%)
$1.64 M(+0.6%)
Sep 2017
-
$406.00 K(-1.7%)
$1.63 M(+0.5%)
Jun 2017
-
$413.00 K(+0.5%)
$1.62 M(+0.7%)
DateAnnualQuarterlyTTM
Mar 2017
-
$411.00 K(+2.8%)
$1.61 M(+1.4%)
Dec 2016
$1.59 M(+12.0%)
$400.00 K(+0.5%)
$1.59 M(+2.5%)
Sep 2016
-
$398.00 K(-1.0%)
$1.55 M(-0.4%)
Jun 2016
-
$402.00 K(+3.3%)
$1.56 M(+0.6%)
Mar 2016
-
$389.00 K(+7.8%)
$1.55 M(+9.1%)
Dec 2015
$1.42 M(+91.2%)
$361.00 K(-10.9%)
$1.42 M(+13.3%)
Sep 2015
-
$405.00 K(+3.1%)
$1.25 M(+21.2%)
Jun 2015
-
$393.00 K(+51.2%)
$1.03 M(+24.0%)
Mar 2015
-
$260.00 K(+34.0%)
$833.00 K(+12.3%)
Dec 2014
$742.00 K(+5.5%)
$194.00 K(+4.3%)
$742.00 K(+3.5%)
Sep 2014
-
$186.00 K(-3.6%)
$717.00 K(+2.1%)
Jun 2014
-
$193.00 K(+14.2%)
$702.00 K(+1.3%)
Mar 2014
-
$169.00 K(0.0%)
$693.00 K(-1.4%)
Dec 2013
$703.00 K(-17.0%)
$169.00 K(-1.2%)
$703.00 K(-25.3%)
Sep 2013
-
$171.00 K(-7.1%)
$941.00 K(+2.5%)
Jun 2013
-
$184.00 K(+2.8%)
$918.00 K(+4.1%)
Mar 2013
-
$179.00 K(-56.0%)
$882.00 K(+4.1%)
Dec 2012
$847.00 K(+76.8%)
$407.00 K(+175.0%)
$847.00 K(+92.5%)
Sep 2012
-
$148.00 K(0.0%)
$440.00 K(+50.7%)
Jun 2012
-
$148.00 K(+2.8%)
$292.00 K(+102.8%)
Mar 2012
-
$144.00 K
$144.00 K
Dec 2011
$479.00 K
-
-

FAQ

  • What is Epizyme annual depreciation & amortization?
  • What is the all time high annual D&A for Epizyme?
  • What is Epizyme annual D&A year-on-year change?
  • What is Epizyme quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Epizyme?
  • What is Epizyme quarterly D&A year-on-year change?
  • What is Epizyme TTM depreciation & amortization?
  • What is the all time high TTM D&A for Epizyme?
  • What is Epizyme TTM D&A year-on-year change?

What is Epizyme annual depreciation & amortization?

The current annual D&A of EPZM is $5.25 M

What is the all time high annual D&A for Epizyme?

Epizyme all-time high annual depreciation & amortization is $5.25 M

What is Epizyme annual D&A year-on-year change?

Over the past year, EPZM annual depreciation & amortization has changed by +$1.26 M (+31.68%)

What is Epizyme quarterly depreciation & amortization?

The current quarterly D&A of EPZM is $1.28 M

What is the all time high quarterly D&A for Epizyme?

Epizyme all-time high quarterly depreciation & amortization is $1.33 M

What is Epizyme quarterly D&A year-on-year change?

Over the past year, EPZM quarterly depreciation & amortization has changed by -$31.00 K (-2.36%)

What is Epizyme TTM depreciation & amortization?

The current TTM D&A of EPZM is $5.23 M

What is the all time high TTM D&A for Epizyme?

Epizyme all-time high TTM depreciation & amortization is $5.26 M

What is Epizyme TTM D&A year-on-year change?

Over the past year, EPZM TTM depreciation & amortization has changed by +$14.00 K (+0.27%)